Literature DB >> 16154220

Treatment-outcome for synchronous head-and-neck and oesophageal squamous cell carcinoma.

Stefan Welz1, Angelika Schmid, Thomas Hehr, Katrin Schulze, Horst-J Feldmann, Wilfried Budach, Michael Bamberg, Claus Belka.   

Abstract

BACKGROUND AND
PURPOSE: Although head & neck and oesophageal carcinomas occur synchronously in up to 12%, almost no data on feasibility and outcome after radiotherapy are available.
MATERIALS AND METHODS: From 1989 to 2002, 24 patients were treated at Tuebingen University and Fulda hospital with a radiation based, curative approach. These were analyzed retrospectively.
RESULTS: The median overall survival was 37 (1-69) months with a few long-term survivors with a median follow-up of 26 months for patients at risk. 7 local recurrences occurred. No major toxicity was seen. DISCUSSION: Even though the prognosis of synchronous head & neck and oesophageal carcinomas is grim, long-term survival is possible. A radiation-based approach is feasible and can be chosen for a curative treatment approach which we recommend.

Entities:  

Mesh:

Year:  2005        PMID: 16154220     DOI: 10.1016/j.radonc.2005.07.004

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

1.  Esophageal squamous cell neoplasia is an independent negative prognostic factor for head and neck cancer patients.

Authors:  Yasuhiko Hamada; Toshiro Mizuno; Kyosuke Tanaka; Masaki Katsurahara; Noriyuki Horiki; Reiko Yamada; Hiroyuki Inoue; Yoshiyuki Takei; Naoyuki Katayama
Journal:  Int J Clin Oncol       Date:  2017-10-24       Impact factor: 3.402

2.  Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre.

Authors:  Maria C Wolf; Franz Zehentmayr; Michael Schmidt; Dieter Hölzel; Claus Belka
Journal:  Radiat Oncol       Date:  2012-04-15       Impact factor: 3.481

3.  Clinical outcomes of synchronous head and neck and esophageal cancer.

Authors:  Jae Won Park; Sang-Wook Lee
Journal:  Radiat Oncol J       Date:  2015-09-30

4.  Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.

Authors:  Yen-Hao Chen; Hung-I Lu; Chih-Yen Chien; Chien-Ming Lo; Yu-Ming Wang; Shang-Yu Chou; Yan-Ye Su; Li-Hsueh Shih; Shau-Hsuan Li
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

5.  Chemoradiotherapy for Synchronous Multiple Primary Cancers with Esophageal Squamous Cell Carcinoma: a Case-control Study.

Authors:  Qi-Wen Li; Yu-Jia Zhu; Wen-Wen Zhang; Han Yang; Yao Liang; Yong-Hong Hu; Bo Qiu; Meng-Zhong Liu; Hui Liu
Journal:  J Cancer       Date:  2017-02-11       Impact factor: 4.207

6.  Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.

Authors:  Yen-Hao Chen; Hung-I Lu; Chih-Yen Chien; Chien-Ming Lo; Yu-Ming Wang; Shang-Yu Chou; Shau-Hsuan Li
Journal:  J Clin Med       Date:  2020-01-10       Impact factor: 4.241

7.  Long-term treatment results and prognostic factors of synchronous and metachronous squamous cell carcinoma of head and neck and esophagus.

Authors:  Jiali Chen; Chunying Shen; Chaosu Hu; Cuihong Wang; Yongxue Zhu; Xueguan Lu
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.